Traduction de «us filing for use » (Néerlandais → Français) :

In 2008 the SOE-USE handled more than 700 files regarding illegal internet medicines and more than 100 “classic” files.
In 2008 the SOE-USE handled more than 700 files regarding illegal internet medicines and more than 100 “classic” files.

d) heeft elke gemachtigd gebruiker die over een elektronische identiteitskaart beschikt toegang tot de toepassingen “Shared Artritis File for Electronic Use (SAFE)”, “Raadpleging van de wilsverklaring inzake euthanasie - eutha-consult”, “ORTHOpedic Prosthesis Identification Data - Electronic Registry - ORTHOpride®”, “Project on cancer of the rectum - Central Image Repository (PROCARE RX)”, “Qermid(c)Pacemakers-Quality Electronic Registration of Medical Implant Devices”, “SMUREG”, “Medico-Administratieve Stromen – Thuisverpleging (MEDADM-INF)”, “ZNA - Zorgportaal – SARAi”, “Registratie van Therapeutische Projecten (TherPro – PatientRegistration)”, “Medega”, “QermidDefibrilateur-Quality Electronic Registration of Medical Implant Devices”, “eHealthBox”, “QermidEndoprothèses-Quality Electronic Registration of Medical Implant Devices”, “QermidPacemakers-Quality Electronic Registration of Medical Implant Devices”, “QermidTuteurs Coronaires- Quality Electronic Registration of Medical Implant Devices”, “Registratiemodule van de Belgische Virtuele Tumorbank”, “Catalogus van de Belgische Virtuele Tumorbank”, “CIVARS – Chapter IV Agreement Requesting System”, “Web Application Metahub”, “Raadpleging van medische kaart”, “TDI - Registratie Module van de “Treatment Demand Indicator””, “eShop - Online bestelling getuigschriften voor verstrekte hulp (Medattest)”, “BNMDR - Belgian NeuroMuscular Disease Registry”, “eHealthConsent”, “Moduledatabank Jeugdhulp Vlaanderen” en “Authentieke bron geneesmiddelen”.
d) chaque utilisateur habilité qui dispose d’une Carte d’Identité Electronique a accès aux applications « Shared Artritis File for Electronic Use (SAFE) », « Consultation de la déclaration anticipée d’euthanasie- eutha-consult », « ORTHOpedic Prosthesis Identification Data - Electronic Registry - ORTHOpride® », « Project on cancer of the rectum - Central Image Repository (PROCARE RX) », « Qermid(c)Pacemakers- Quality Electronic Registration of Medical Implant Devices », « SMUREG », « Flux Medico-Administratifs - Infirmier A Domicile (MEDADM-INF) », « ZNA - Zorgportaal – SARAi », « Enregistrement des projets thérapeutiques (TherPro – PatientRegistration) », « Medega », « QermidDefibrilateur-Quality Electronic Registration of Medical Implant Devices », « eHealthBox », « QermidEndoprothèses- Quality Electronic Registration of Medical Implant Devices », « QermidPacemakers- Quality Electronic Registration of Medical Implant Devices », « QermidTuteurs Coronaires-Quality Electronic Registration of Medical Implant Devices », « Module d’enregistrement de la Tumorothèque Virtuelle Belge », « Catalogue de la Tumorothèque Virtuelle Belge », « CIVARS – Chapter IV Agreement Requesting System », « Web Application Metahub », « Consultation des cartes médicales », « TDI

eCare-SAFE - Voeding en consultatie van het register " Shared Arthritis File for Electronic use"
eCare-SAFE - Alimentation et consultation du registre " Shared Arthritis File for Electronic use"

eCare-SAFE - Voeding en consultatie van het register " Shared Arthritis File for Electronic use" | eHealth
eCare-SAFE - Alimentation et consultation du registre " Shared Arthritis File for Electronic use" | eHealth

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission
Advisory commission which is consulted e.g. in cases of non-availability of medicines Commission for the approval of institutions assigning preliminary approvals for scientific events Commission for the establishment of retail pharmacies and chambers of appeal (Frenchspeaking chamber and Dutch-speaking chamber) Commission for the recognition of pharmacists-clinical biologists Commission for the supervision of advertising for medicines for human use Evaluation commission for active implantable medical devices Evaluation commission for homeopathic medicines Evaluation commission for medical devices Evaluation commission for medicines for human use Evaluation commission for medicines for veterinary use Evaluation commission for traditional herbal medicines Pharmacopoeia commission

The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.
The FAMHP intends to significantly increase its involvement in the lifecycle of immunological medicines for veterinary use by providing scientific advice, evaluating applications for clinical trials in Belgium, adopting (co-)rapporteurships for CP, MRP and DCP for MA of vaccines for veterinary use and developing pharmacovigilance and inspection activities.

Vaccines 24 –– Vaccines for human use 24 –– Vaccines for veterinary use 28
Vaccines 24 –– Vaccines for human use 24 –– Vaccines for veterinary use 28

Therefore, each advert for a medicine for human use destined for use by the general public is
Therefore, each advert for a medicine for human use destined for use by the general public is

The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.
The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.